companydata.dkMACURE PHARMA ApS: Financial statements 2014
CVR: 35234748
MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 214,151 and a net result of DKK 66,464. Equity amounted to DKK 416,751. The solvency ratio was 13.1%.
- Gross Profit
- 214,151 kr.
- Profit/Loss
- 66,464 kr.
- Equity
- 416,751 kr.
- Total Assets
- 3,181,866 kr.
Keep an eye on MACURE PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
MACURE PHARMA ApS has published its interim report for the period May 1, 2013 – December 31, 2013.
As of May 13, 2014, Bogføring Danmark ApS has been appointed auditor of MACURE PHARMA ApS.
As of March 5, 2014, Mads Renlef Henningsen is registered as adm. dir. of MACURE PHARMA ApS.
As of March 5, 2014, Simon Søberg Jørgensen has stepped down as director of MACURE PHARMA ApS.
About MACURE PHARMA ApS
MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity amounted to DKK 18,033,649.